| Symbotic (SYM) is awaiting the acceptance of its SimMicro (micro-fulfillment) prototypes for Walmart, a critical step to unlock a substantial $5 billion backlog, and is also expected to announce progress in entering the perishables vertical. | Within the next 12 months (by February 2027) for prototype acceptance; within 12-18 months for perishables announcements | 2026-06-04 | 2027-02-28 | Successful prototype acceptance would trigger a significant revenue stream and validate Symbotic's expansion into micro-fulfillment, while entry into the perishables market would open a massive new addressable market, showcasing the versatility and cost-saving potential of its automation systems. | Ticker | theme_composer | SYM | 1 | 0.0005 | 1.18 | 0.92 | | 1.0 | 0.0531 | 2026-06-04 | False | 1 | 0.0055 | 0.6007 | | Theme composer | | |
| Ouster (OUST) is expected to continue expanding its BlueCity smart infrastructure deployments and secure significant multi-year defense contracts, further validating its lidar technology in high-value applications. | Ongoing, with significant announcements in Q2/Q3 2026 | 2026-04-23 | 2026-12-31 | Continued large-scale deployments of BlueCity demonstrate Ouster's leadership in smart infrastructure and its software-attached model, while securing defense contracts would diversify revenue and prove the applicability of its lidar technology in critical security and defense markets. | Theme | theme_composer | OUST | 1 | 0.0001 | 1.18 | 0.92 | Regulatory/Policy | 1.35 | 0.0095 | 2026-06-04 | False | 1 | 0.0006 | 0.0907 | | Theme composer | | |
| Recognition of the majority of Ouster's expected total royalty revenue for 2026, which is projected to be less than $5 million. | For 2026, total royalty revenue is expected to be less than $5 million, with the majority of that amount expected to be recognized in the back half of the year. | 2026-07-01 | 2026-12-31 | This represents a significant reduction in royalty revenue compared to 2025, highlighting the need for strong product revenue growth to offset this decline and maintain overall revenue trajectory. | Ticker | | | | | | | | | | | | | | | earnings_transcript | OUST (ticker) | OUST_9081abcb | 2026-03-02 |
| StereoLabs' revenue performance, with approximately 60% of its 2026 revenue historically occurring in the second half of the year. | seasonally stronger in the second half of the year with approximately 60% of the revenue occurring during this period. | 2026-07-01 | 2026-12-31 | Strong performance from StereoLabs in H2 2026 is crucial for the combined company's overall revenue growth and margin profile, validating the acquisition's accretive nature. | Ticker | | | | | | | | | | | | | | | earnings_transcript | OUST (ticker) | OUST_c2a00861 | 2026-03-02 |
| The market introduction of PCI Express Gen 6 CPUs and GPUs, leading to a rebound in Teledyne's protocol analyzer sales within the Instrumentation segment. | second half of the year | 2026-07-01 | 2026-12-31 | This would drive sales growth in the higher-margin test and measurement business, contributing to the expected full-year growth and margin improvement in the Instrumentation segment. | Ticker | | | | | | | | | | | | | | | earnings_transcript | TDY (ticker) | TDY_3be47bd9 | 2026-04-22 |
| CV7, Ambarella's first four-nanometer chip, beginning to generate revenue. | fourth quarter of this year | 2026-11-01 | 2027-01-31 | Successful revenue generation from CV7 would validate demand for higher AI performance chips and contribute to future revenue growth, positively impacting valuation and investor sentiment. | Ticker | | | | | | | | | | | | | | | earnings_transcript | AMBA (ticker) | AMBA_405789d9 | 2026-02-26 |
| Cognex (CGNX) is targeting a 25% adjusted EBITDA margin run-rate by the end of 2026, driven by ongoing cost reductions and portfolio optimization efforts. | By end of 2026 | 2026-12-31 | 2026-12-31 | Achieving this ambitious margin target would validate Cognex's strategic operating model transformation and demonstrate strong structural profitability, reinforcing investor confidence in its financial health and efficiency within the machine vision sector. | Theme | theme_composer | CGNX | 1 | 0.0003 | 1.18 | 1.05 | Regulatory/Policy | 1.35 | 0.0424 | 2026-06-04 | False | 1 | 0.0024 | 0.4066 | | Theme composer | | |
| First silicon revenue generation from Ambarella's initial semi-custom/custom ASIC design win. | early next year | 2027-02-01 | 2027-04-30 | This would mark the commercialization of Ambarella's new ASIC business model, demonstrating its ability to translate design wins into actual revenue and potentially validating a new growth vector. | Ticker | | | | | | | | | | | | | | | earnings_transcript | AMBA (ticker) | AMBA_a6c0b0c8 | 2026-02-26 |
| A significant shift in the composition of Ouster's defense sector revenue, moving from research and development to large-scale deployment of fully autonomous systems on the battlefield. | a number of more years / couple more years for sure | 2028-01-01 | 2029-12-31 | This would represent a major new, long-term revenue stream and market expansion for Ouster, validating its investment in defense certifications and advanced autonomous capabilities. | Ticker | | | | | | | | | | | | | | | earnings_transcript | OUST (ticker) | OUST_953edb1b | 2026-03-02 |
| Humanoid robotics reaching a market scale that significantly impacts Ouster's top-line revenue, moving beyond pioneering research to widespread commercial deployment. | a little longer / couple more years for sure | 2028-01-01 | 2029-12-31 | This would open up a substantial new market opportunity for Ouster's combined lidar and camera sensing systems, validating its strategic investment in this emerging field. | Ticker | | | | | | | | | | | | | | | earnings_transcript | OUST (ticker) | OUST_b360ffa2 | 2026-03-02 |